All are invited to submit abstracts of scientific research to be considered for presentation during the NAMS Annual Meeting.
Submission Guidelines
Abstracts must be submitted using this online form.
ONLINE FORM
The deadline for regular submission is April 30, 2021. The deadline for late-breaking submission is July 1, 2021. Guidelines follow:
- Each author may submit up to five abstracts for consideration.
- There is a limit of 4,545 characters for the text of your submission. The character count includes spaces, title, authors, institutions, tables, and images. You will be advised of your character count usage throughout the submission process as you save and move to the next step. Your character count will also be displayed in the bar at the top of your submission.
- Information submitted for consideration must not be identical to that presented at any meeting prior to the NAMS Annual Meeting and the study must not have been published as of the submission date.
- Authors who wish to be considered for a New Investigator Award must have earned their degree within seven years, and not previously been given this award. Proof of eligibility is required.
- All abstracts presented at the NAMS Annual Meeting will be published in Menopause.
- NAMS reserves the right not to review an abstract, or not to publish an abstract in Menopause, if the abstract submission does not conform to all requirements.
- Abstracts must be submitted in English, in a structured format.
- Late-breaking submissions must be truly late-breaking, meaning the material was not available for submission by the regular deadline of April 30, 2021.
Types of Presentations
- Oral Presentation: The top scoring abstracts will be invited to be presented from the podium in a Scientific Session held during the NAMS Annual Meeting.
- Poster Presentation: All other abstract submissions will be considered for poster presentation during the Poster Session. Up to three Poster Prizes will be awarded, with a top prize of $1,000.
Review and Selection Process
All abstracts are subjected to a blinded review by three independent members of the NAMS Abstract Review Committee. After being sent to the Abstract Review Committee for review, submissions may not be altered. Abstracts will be scored as follows:
- Approach
- Innovation
- Impact of study findings on field of menopause
- Clarity
Approach: Is the study design appropriate to the study aims? How strong are the research methods with respect to selection of participants (inclusion/exclusion) and procedures used to assess outcome measures? Is the analytic approach appropriate to the study goals? Do the study conclusions flow from the results? Are study limitations recognized?
Innovation: Does the project challenge and shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation or interventions?
Impact of Study: Does the project address an important problem or a critical barrier to progress in the field of women's health at midlife and beyond? Does the project improve scientific knowledge, technical capability and/or clinical practice? Does the project change the concepts, methods technologies, treatments, services, or preventative interventions that drive the field of women's health at midlife and beyond?
Clarity: Is the research study presented in a clear and easily understandable manner? Are the goals of the science, the findings, and the interpretation readily accessible to the audience?
Sample Abstracts
View the abstracts for the Top Scoring Oral Presentations and the Poster Prize Winners from a past NAMS Annual Meeting.
Notification of Receipt and Acceptance
- Receipt of abstract submissions will be acknowledged via email to the contact author.
- After the review process is complete, authors will be notified by July 15, 2021, regarding the acceptance or rejection of their submissions.
Cancellations
Authors of accepted presentations who do not present their work or fail to have it presented by a co-author will not be permitted to have abstracts considered for presentation at the NAMS Annual Meeting for the following two years. Exceptions will be considered if NAMS is given prompt notification of extreme unforeseen circumstances.